Styrning AbbVie Inc.

ABBV

US00287Y1091

Farmaceutiska produkter

Marknaden stängd - Nyse Andra börsplatser 22.00.03 2026-02-13			5-dagars förändring	Förändring 1 jan.
231,50 ^USD	+1,76 %		+3,61 %	+1,32 %

02-13	AbbVie Inc. Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium, Feb-13-2026 10:00 AM
02-13	PriorNilsson Globala Utdelare minskade 1,87 procent i januari - lyfter fram Abbvie	FW

Verkställande utskott: AbbVie Inc.

Verkställande direktör

Innehade positionerSedan

Robert Michael

55 år

Chief Executive Officer

2024-07-01

Roopal Thakkar

Chief Tech/Sci/R&D Officer

2003-01-01

Perry Siatis

General Counsel	2022-10-17
Corporate Secretary	2022-10-17

Azita Saleki-Gerhardt

62 år

Chief Operating Officer

2023-07-01

Scott Reents

59 år

Director of Finance/CFO

2022-06-23

Tim Richmond

59 år

Human Resources Officer

2013-01-01

Liz Shea

Investor Relations Contact

2013-01-01

Sammansättning av styrelsen: AbbVie Inc.

Direktör

KommittéerSedan

Robert Michael

55 år

Chairman

2025-07-01

Roxanne Austin

65 år

Audit Committee
Governance Committee
Compensation Committee Chair	2013-01-01
Audit Committee Chair	2021-05-13
Finance Committee	2021-05-13
Governance Committee Chair	2025-12-01
Nominating Committee Chair	2025-12-01

Edward Rapp

68 år

Audit Committee	2013-01-01
Governance Committee
Nominating Committee
Compensation Committee	2021-08-20
Audit Committee Chair	2021-08-20

Rebecca Roberts

73 år

Compensation Committee	2015-02-13
Governance Committee Chair	2011-01-01
Governance Committee
Nominating Committee

Thomas Freyman

71 år

Compensation Committee	2020-05-08
Audit Committee Chair	2020-05-08
Governance Committee Chair
Nominating Committee Chair

Frederick Waddell

72 år

Executive Committee
Compensation Committee Chair
Compensation Committee
Audit Committee Chair

Robert Alpern

75 år

Governance Committee	2013-10-01
Nominating Committee	2013-10-01
Compensation Committee

Brett Hart

56 år

Governance Committee	2016-01-01
Nominating Committee	2016-01-01
Compensation Committee Chair

Thomas Falk

67 år

Governance Committee Chair	2024-05-02
Nominating Committee Chair	2024-05-02
Audit Committee	2025-05-09

William Burnside

74 år

Executive Committee
Audit Committee	2013-01-01

Melody Meyer

68 år

Compensation Committee
Audit Committee	2017-01-01

Jennifer Davis

54 år

Governance Committee	2023-10-11
Nominating Committee	2023-10-11

Susan Quaggin

62 år

Director/Board Member	2023-10-11
Independent Dir/Board Member	2023-10-11

Senaste Tillsättningar: AbbVie Inc.

01-29	Definium Therapeutics utser Roger Adsett till styrelsen från och med den 29 januari 2025	CI
01-12	FTI Consulting, Inc. utser Dan Scorpio och Heather Wilson till Senior Managing Directors	CI
01-08	PRESSDIGEST–Wall Street Journal – 8 januari	RE
01-07	SAB Biotherapeutics, Inc. tillkännager förändringar i styrelsen, gällande från och med 7 januari 2026	CI
12-15	Spruce Biosciences, Inc. utnämner Keli Walbert till styrelseledamot	CI
12-10	Fresenius Medical Care tillkännager ny global medicinsk chef och förändringar i styrelsen	CI
11-12	LB Pharmaceuticals utser Kaya Pai Panandiker till kommersiell chef	CI

Mer nyheter

Före detta tjänstemän och direktörer: AbbVie Inc.

Insider

Innehade positioner

SedanTill

Glenn Tilton

Director/Board Member	2013-01-01	2025-07-01
Independent Dir/Board Member	2013-01-01	2025-07-01

Richard Gonzalez

Chief Executive Officer	2013-01-01	2024-07-01
Chairman	2013-01-01	2025-07-01

Kevin Buckbee

Comptroller/Controller/Auditor

2023-03-01

2025-03-01

Carrie Strom

Corporate Officer/Principal

2020-05-08

2025-02-01

Thomas Hudson

Chief Tech/Sci/R&D Officer	2019-07-01	2024-07-10
Corporate Officer/Principal	2016-01-01	2019-07-01

Jane Woo

Public Communications Contact

2021-04-01

2024-04-01

Katherine Rielly-Gauvin

Corporate Officer/Principal

2013-01-01

2023-07-01

Neil Gallagher

Chief Tech/Sci/R&D Officer	2020-01-01	2023-04-01
Corporate Officer/Principal	2017-11-01	2020-01-01

Frank Benenati

Public Communications Contact

2021-04-01

2023-04-01

Henry Gosebruch

Corporate Officer/Principal

2015-12-01

2023-02-01

Chris Boone

Corporate Officer/Principal

2023-01-02

Mohamed Zaki

Corporate Officer/Principal

2018-09-01

2022-12-01

Matthew Farber

Corporate Officer/Principal

2022-06-01

Michael Severino

Chief Tech/Sci/R&D Officer	2014-06-01	2018-12-17
President	2018-12-17	2022-05-31

Edward Liddy

Director/Board Member	2013-01-01	2022-05-11
Independent Dir/Board Member	2013-01-01	2022-05-11

Kate C. Liebelt

Corporate Officer/Principal

2020-06-01

2022-04-30

Todd D. Bosse

Investor Relations Contact

2021-12-01

Nataskia Lampe

Corporate Officer/Principal

2012-03-01

2021-08-01

Carlos Alban

Director/Board Member	2018-12-17	2021-03-01
Corporate Officer/Principal	2013-01-01	2021-03-01

Jose-Carlos Gutiérrez-Ramos

Corporate Officer/Principal

2020-02-01

2021-01-01

Adelle Infante

Public Communications Contact

2020-12-01

Janet Hammond

Corporate Officer/Principal

2016-11-01

2020-08-01

Ronald O. Robison

General Counsel	2013-01-14	-
Corporate Officer/Principal	-	2020-04-01

Vusi Moyo

Public Communications Contact

2020-04-01

Myra Rosario Herrle

Corporate Officer/Principal

2014-08-01

2020-03-01

Frank A. Jaeger

Sales & Marketing

2014-01-01

2019-08-01

Scott Brun

Corporate Officer/Principal

2019-03-01

Nadia Dac

Corporate Officer/Principal

2014-12-01

2019-03-01

John Westwater

Director/Board Member

2018-04-01

2018-12-31

Jim Sullivan

Private Equity Investor

2013-01-01

2018-12-01

Melanie Gloria

Corporate Officer/Principal

2014-08-01

2018-07-01

Graig Suvannavejh

Corporate Officer/Principal

2017-03-01

2018-07-01

Elizabeth Thompson

Chief Tech/Sci/R&D Officer

2015-09-01

2018-05-01

Paul Schwichtenberg

Corporate Officer/Principal

2013-10-01

2018-04-01

Gary Gordon

Corporate Officer/Principal

2013-01-01

2018-04-01

Mark Stenhouse

Corporate Officer/Principal

2016-10-01

2018-03-01

Sujay Kango

Corporate Officer/Principal

2017-01-01

2018-02-01

Shao Lee Lin

Corporate Officer/Principal

2015-04-01

2017-12-01

Thomas A. Hurwich

Comptroller/Controller/Auditor

2017-02-28

Sharon Curran

Corporate Officer/Principal

2012-01-01

2017-01-01

Francisco Velasco

Corporate Officer/Principal

2009-06-01

2016-06-01

Roy S. Roberts

Director/Board Member	2013-01-01	2016-05-06
Independent Dir/Board Member	2013-01-01	2016-05-06

Rita Jain

Corporate Officer/Principal

2013-01-01

2016-01-01

Renee Tannenbaum

Corporate Officer/Principal

2012-10-01

2016-01-01

Maria Rivas

Chief Tech/Sci/R&D Officer

2012-08-01

2015-12-01

Peter Heerma

Corporate Officer/Principal

2012-12-01

2015-11-01

David H. Donabedian

Corporate Officer/Principal

2015-08-01

Paul Wierbicki

General Counsel

2014-03-01

2015-05-01

Jennifer Mound Smoter

Public Communications Contact

2012-08-01

2015-03-01

Barry Regan

Chief Operating Officer	2013-01-01	2015-03-01
Corporate Officer/Principal	-	-

Steven N. Gersten

Compliance Officer

2015-01-01

Alysa Spittle

Public Communications Contact

2013-01-01

2015-01-01

Gary Winer

Corporate Officer/Principal

2014-04-01

2015-01-01

Mohit Rawat

Corporate Officer/Principal

2013-08-01

2014-05-01

Donald Frail

Corporate Officer/Principal

2014-01-01

Lily Chang

Private Equity Analyst

2013-01-01

2014-01-01

Lars Kielhorn

Corporate Officer/Principal

2011-01-01

2014-01-01

John Leonard

Chief Tech/Sci/R&D Officer

2013-01-01

2014-01-01

Jose Rivera

Compliance Officer

2013-01-01

2013-09-01

George Avgerinos

Corporate Officer/Principal

2008-07-01

2013-07-01

Laura Schumacher

General Counsel	2013-01-01	-
Corporate Secretary	2014-02-10	2022-10-17

Greg W. Linder

Director/Board Member

2012-12-31

Sharon Greenlees

Investor Relations Contact	2016-01-01	2018-01-01
Corporate Officer/Principal	2018-01-01	-

Larry Peepo

Investor Relations Contact

Glenn S. Warner

Corporate Officer/Principal

James P. Sullivan

Corporate Officer/Principal

Derrell Porter

Sales & Marketing

Ann Tomlin

Human Resources Officer

Björn Cochlovius

Corporate Officer/Principal

Jordan Dubow

Corporate Officer/Principal

Barbara McGovern

Corporate Officer/Principal

Youssef Bennani

Corporate Officer/Principal

Karl G. Trass

Corporate Officer/Principal

David Laskow-Pooley

Director/Board Member

Gregory Miley

Public Communications Contact	-	-
General Counsel	-	-

Christopher Kurtz

Corporate Officer/Principal

Star Seyedkazemi

Corporate Officer/Principal

Saeed Motahari

Corporate Officer/Principal

Karen Hale

Compliance Officer

William Chase

Chief Administrative Officer	2018-10-19	-
Director of Finance/CFO	-	2018-10-19

Douglas Feltner

Corporate Officer/Principal

Gentry Lassiter

Public Communications Contact

Paulo Vega

Corporate Officer/Principal

Kimberly Davis-Wells

Corporate Officer/Principal

Li Malmberg

Corporate Officer/Principal

Denelle Waynick

General Counsel

Åldersfördelning av chefer

Könspartitet

Man	18
Kvinna	6

Vars verkställande kommitté

Man	6
Kvinna	1

Varav Direktörer

Man	9
Kvinna	4

Revisioner

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Nej

Controverses sur les droits de l'Homme

Nej

Controverses Subventions fiscales

Nej

Conforme à la finance Islamique

Nej

AbbVie Inc. är specialiserat på forskning och utveckling av terapeutiska läkemedel. Produkterna är avsedda för behandling av reumatoid artrit, psoriasis, Crohns sjukdom, sköldkörtelsjukdom, Parkinsons sjukdom, HIV, komplikationer av mukoviscidos, låga testosteronnivåer och komplikationer i samband med kronisk njursjukdom. Nettoomsättningen fördelar sig geografiskt enligt följande: USA (76,4%), Tyskland (2,6%), Japan (2%), Kanada (1,9%), Kina (1,6%), Frankrike (1,4%), Spanien (1%), Storbritannien (0,9%), Italien (0,9%), Brasilien (0,8%), Australien (0,8%) och övriga (9,7%).

Anställda

55 000

Sektor

Farmaceutiska produkter

Kalender

04-24 - Q1 2026

Mer information om företaget